Bo Wiinberg is a Senior Biotech Advisor at Biobridge Partners and an Entrepreneur in Residence at BioInnovation Institute for the SpaceM and OmniTx projects. He has a decade of experience from Novo Nordisk, building and leading several units across the pharma value chain from discovery to commercialization. At Novo Nordisk, Bo has, among others, held positions of Director & Head of Haemophilia Biology, R&D Strategy Director, and Senior Director – Head of Strategy & Operations.